FREQUENCY OF PERITONEAL INFECTIONS AMONG PATIENTS UNDERGOING CONTINUOUS PARACENTESIS WITH AN INDWELLING CATHETER
AbstractBackground: Ascites is a common clinical manifestation of advanced liver disease which can bemanaged with repeated large volume paracentesis. We sought to determine if continuous paracentesis viaplacement of an indwelling catheter for the management of ascites is safe and effective. Methods: Weplaced 38 peritoneal drainage catheters in 30 patients for durations ranging from 1–10 days. Patientsunderwent ascites fluid culture and cell count determinations immediately before and after the completionof paracentesis. Serum WBC count, BUN and creatinine levels were available on all patients before andafter paracentesis. The descriptive data were analysed to assess the rate of peritoneal infections, change inrenal function and ultimate clinical outcome of patients. Results: A mean 12.73 litres of peritoneal fluidwas removed via continuous peritoneal drainage accomplished with the use of an indwelling abdominalcatheter. Eight peritoneal cultures obtained after paracentesis grew out. The mean peritoneal cell countbefore and after paracentesis in each subject did not show evidence for spontaneous bacterial peritonitis.Five patients underwent successful liver transplantation (OLTX) and did not develop any peritonealinfections post OLTX. Conclusion: Continuous large volume paracentesis using an indwellingabdominalcatheter for several days is effective in removing large volumes of peritoneal fluid in patients with endstage-liver-disease (ESLD). The peritoneal fluid can grow out bacteria if it is left in the abdomen for ≥3days.Keywords: Large volume Paracentesis, indwelling
Inturri P, Graziotto A, Rossaro L. Treatment of ascites: old and
new remedies. Dig Dis 1996;14:145–56.
Runyon BA. Treatment of patients with cirrhosis and ascites.
Semin Liver Dis 1997;17:249–60.
Pozzi M, Osculati G, Boari G, Serboli P, Colombo P, Lambrughi
C, et al. Time course of circulatory and humoral effects of rapid
total paracentesis in cirrhotic patients with tense, refractory
ascites. Gastroenterology 1994;106:709–19.
Gines A, Fernandez-Esparrach G, Monescillo A, Vila C,
Domènech E, Abecasis R, et al. Randomized trial comparing
albumin, dextran 70, and polygeline in cirrhotic patients with
ascites treated by paracentesis. Gastroenterology 1996;111:1002–
Appelqvist P, Silvo J, Salmela L, Kostiainen S. On the treatment
and prognosis of malignant ascites: is the survival time
determined when the abdominal paracentesis is needed? J Surg
Mallory A, Schaefer JW. Complications of diagnostic
paracentesis in patients with liver disease. JAMA 1978;239:628–
Tito L, Gines P, Arroyo V, Planas R, Panés J, Rimola A, et al.
Total paracentesis associated with intravenous albumin
management of patients with cirrhosis and ascites.
Sola R, Vila MC, Andreu M, Oliver MI, Coll S, Gana J, et al.
Total paracentesis with dextran 40 vs diuretics in the treatment of
ascites in cirrhosis: a randomized controlled study. J Hepatol
Helzberg JH, Greenberger NJ. Peritoneovenous shunts in
malignant ascites. Dig Dis Sci 1985;30:1104–7.
Cheung DK, Raaf JH. Selection of patients with malignant ascites
for a peritoneovenous shunt. Cancer 1982;50:1204–9.
Runyon BA. Management of adult patients with ascites caused by
cirrhosis. Hepatology 1998;27:264–72.
O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR.
Tunneled peritoneal catheter placement under sonographic and
fluoroscopic guidance in the palliative treatment of malignant
ascites. AJR Am J Roentgenol 2001;177:615–8.
Richard HM 3rd, Coldwell DM, Boyd-Kranis RL Murthy R, Van
Echo DA. Pleurx tunneled catheter in the management of
malignant ascites. J Vasc Interv Radiol 2001;12:373–5.
Barnett TD, Rubins J. Placement of a permanent tunneled
peritoneal drainage catheter for palliation of malignant ascites: a
simplified percutaneous approach. J Vasc Interv Radiol
Lee A, Lau TN, Yeong KY. Indwelling catheters for the
management of malignant ascites. Support Care Cancer
Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi
A, et al. Limitations of serum creatinine level and creatinine
clearance as filtration markers in cirrhosis. Arch Intern Med
Jeffries MA, Stern MA, Gunaratnam NT, , Fontana RJ.
Unsuspected infection is infrequent in asymptomatic outpatients
with refractory ascites undergoing therapeutic paracentesis. Am J
Chu CM, Chang KY, Liaw YF. Prevalence and prognostic
significance of bacterascites in cirrhosis with ascites. Dig Dis Sci
Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a
variant of spontaneous bacterial peritonitis. Hepatology
Sell TL. Culture-negative neurocytic ascites. Hepatology